Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Grey

Showing results (31-40 of 256) with videos related to

Pageof 26
Sort By:
The Lancet. Diabetes & Endocrinology|May 22, 2016
Inaccurate dissemination of the MAVIDOS trial resultsAndrew Grey, Mark J Bolland
Menopause (New York, N.Y.)|August 25, 2023
Letters to the EditorMark J Bolland, Andrew Grey
Lancet (London, England)|August 29, 2018
A closer look at SCOOP: screening for fracture preventionMark J Bolland, Andrew Grey
BMJ (Clinical Research Ed.)|May 28, 2017
Cessation of strontium ranelate supplyMark J Bolland, Andrew Grey
Archives of Osteoporosis|November 26, 2015
Different outcomes of meta-analyses and data inconsistency: response to comments by PfeiferMark J Bolland, Andrew Grey
Evidence-Based Nursing|August 31, 2013
Calcium supplements associated with increased risk of cardiovascular death in men but not womenMark J Bolland, Andrew Grey
BMJ (Clinical Research Ed.)|July 11, 2014
Are trials of vitamin D with mortality as an endpoint really needed?Mark J Bolland, Andrew Grey
Therapeutics and Clinical Risk Management|March 25, 2008
Differences between the bisphosphonates for the prevention and treatment of osteoporosisAndrew Grey, Ian R Reid
The Journal of Clinical Endocrinology and Metabolism|February 12, 2010
Disparate outcomes from applying U.K. and U.S. osteoporosis treatment guidelinesMark J Bolland, Andrew Grey
The New Zealand Medical Journal|February 12, 2026
Is a clinician-researcher career viable in New Zealand?Mark J Bolland, Andrew Grey
Pageof 26

Showing results (31-40 of 256) with videos related to

Sort By:
Pageof 26
The Lancet. Diabetes & Endocrinology|May 22, 2016
Inaccurate dissemination of the MAVIDOS trial resultsAndrew Grey, Mark J Bolland
Menopause (New York, N.Y.)|August 25, 2023
Letters to the EditorMark J Bolland, Andrew Grey
Lancet (London, England)|August 29, 2018
A closer look at SCOOP: screening for fracture preventionMark J Bolland, Andrew Grey
BMJ (Clinical Research Ed.)|May 28, 2017
Cessation of strontium ranelate supplyMark J Bolland, Andrew Grey
Archives of Osteoporosis|November 26, 2015
Different outcomes of meta-analyses and data inconsistency: response to comments by PfeiferMark J Bolland, Andrew Grey
Evidence-Based Nursing|August 31, 2013
Calcium supplements associated with increased risk of cardiovascular death in men but not womenMark J Bolland, Andrew Grey
BMJ (Clinical Research Ed.)|July 11, 2014
Are trials of vitamin D with mortality as an endpoint really needed?Mark J Bolland, Andrew Grey
Therapeutics and Clinical Risk Management|March 25, 2008
Differences between the bisphosphonates for the prevention and treatment of osteoporosisAndrew Grey, Ian R Reid
The Journal of Clinical Endocrinology and Metabolism|February 12, 2010
Disparate outcomes from applying U.K. and U.S. osteoporosis treatment guidelinesMark J Bolland, Andrew Grey
The New Zealand Medical Journal|February 12, 2026
Is a clinician-researcher career viable in New Zealand?Mark J Bolland, Andrew Grey
Pageof 26